To further establish whether the high expression of FSTL3 made ICB resistance dependent on the increase of IDO1, mouse subcutaneous tumor models were constructed by using FSTL3-OE MC38 cells and a combination therapy of anti-PD1 antibody and 1-MT was administered. This evidence concerns the gene IDO1 and neoplasm.